GPS Wealth Strategies Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$83.6K Sell
3,357
-9,098
-73% -$229K 0.07% 166
2025
Q3
$317K Sell
12,455
-1,820
-13% -$44.9K 0.03% 262
2025
Q2
$346K Buy
14,275
+329
+2% +$7.67K 0.04% 230
2025
Q1
$353K Sell
13,946
-2,131
-13% -$55.8K 0.05% 219
2024
Q4
$427K Sell
16,077
-2,475
-13% -$67.1K 0.05% 192
2024
Q3
$537K Sell
18,552
-1,501
-7% -$43.8K 0.07% 171
2024
Q2
$561K Sell
20,053
-3,000
-13% -$82.6K 0.08% 145
2024
Q1
$640K Sell
23,053
-1,281
-5% -$35.5K 0.1% 134
2023
Q4
$701K Buy
24,334
+457
+2% +$13.8K 0.13% 120
2023
Q3
$792K Buy
23,877
+8,293
+53% +$293K 0.15% 112
2023
Q2
$572K Buy
15,584
+1,310
+9% +$51K 0.11% 140
2023
Q1
$582K Sell
14,274
-2,243
-14% -$96.9K 0.12% 130
2022
Q4
$846K Buy
16,517
+184
+1% +$8.82K 0.25% 70
2022
Q3
$715K Buy
16,333
+467
+3% +$22.7K 0.18% 94
2022
Q2
$832K Buy
15,866
+20
+0.1% +$1.02K 0.21% 81
2022
Q1
$820K Sell
15,846
-522
-3% -$27.1K 0.19% 73
2021
Q4
$967K Buy
16,368
+1,021
+7% +$50.6K 0.21% 67
2021
Q3
$660K Buy
15,347
+65
+0.4% +$2.88K 0.16% 91
2021
Q2
$598K Buy
15,282
+1,329
+10% +$51.7K 0.15% 92
2021
Q1
$505K Buy
13,953
+989
+8% +$35.1K 0.15% 95
2020
Q4
$477K Sell
12,964
-235
-2% -$8.62K 0.17% 90
2020
Q3
$460K Buy
+13,199
New +$463K 0.19% 85

Other funds holding PFE

GPS Wealth Strategies Group's PFE Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Pfizer (PFE) stake by 73% in Q4 2025, selling an estimated $229K and leaving 3,357 shares worth $83.6K. The position accounts for 0.07% of the portfolio, ranked #166.

GPS Wealth Strategies Group first reported a position in PFE in Q3 2020 and has held it in 22 quarters since. The position peaked at $967K in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • GPS Wealth Strategies Group held 3,357 shares of Pfizer worth $83.6K as of Q4 2025.
  • GPS Wealth Strategies Group sold 9,098 Pfizer shares in Q4 2025, an estimated $229K.
  • Pfizer made up 0.07% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #166 holding.
  • GPS Wealth Strategies Group first reported a position in Pfizer in Q3 2020 and has held it in 22 quarters since.
  • GPS Wealth Strategies Group's Pfizer position peaked at $967K in Q4 2021.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.